1620 Investment Advisors, Inc. Novo Nordisk A S Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 131 shares of NVO stock, worth $10,714. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131
Previous 176
25.57%
Holding current value
$10,714
Previous $20,000
45.0%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,860Shares Held
333MCall Options Held
6.55MPut Options Held
7.8M-
Jennison Associates LLC19.9MShares$1.63 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.17 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.17 Billion0.14% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.06 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.03 Billion0.44% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $185B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...